Introduction
The presence of a stem cell reservoir in epidermis was conceptually proposed in the 1970s, and the demonstration of this presence in human skin was obtained ten years later, through the first clinical use of cultured keratinocytes to treat large burn wounds [1, 2] and the formation of repopulating colonies of keratinocytes observed in irradiated skin in vivo [3, 4] . Hence, stem cells have been frequently proposed as the major target of ionizing radiation (IR) in skin, and notably as the major cellular origin of adverse tissue reactions and skin cancer. However, the precise identification of the actual target cells is still under investigation. This review will cover the mechanisms of skin reactions and carcinogenesis after irradiation, with respect to the response of human stem cells to this genotoxic stress.
General features of skin
The skin is the largest organ of the human body, comprising between 15 and 20% of the total body weight, with a surface area of $2 m 2 . Skin performs numerous functions, including thermoregulation, sensory perception, excretion and absorption, as well as protection from insults, infection and dehydration. It consists of two tissue types; the epidermis -an external stratified, nonvascularised epithelium, and an underlying connective tissue called the dermis -consisting largely of dense fibrous components produced by fibroblasts. As the early skin reactions to radiation and the majority of human skin cancers have an epidermal origin, this review focuses on the epidermal compartment in the human species.
The epidermis
The epidermis is the outermost layer of human skin. It forms the waterproof, protective wrap over the body surface and is made up of a stratified squamous epithelium with an underlying basal lamina. The total thickness is usually between 20 and 100 mm thick, depending on body location, going up to 1.4 mm on palms and soles. The epidermis consists of four main types of cells: keratinocytes, melanocytes, Langerhans cells and Merkel cells. Keratinocytes, the cells that make the keratin proteins, are the predominant type of cells in the epidermis, and it has been evaluated that the epidermis of a single human being comprises approximately 8 10 10 basal keratinocytes [5] . At the lowermost portion of the epidermis, named the basal layer, are immature, proliferating keratinocytes, responsible for keratinopoiesis and epidermis renewal, which is completed every 3-5 weeks. Cell proliferation in epidermis has been characterized by the labelling index in the basal layer, which represents the fraction of cells duplicating their DNA, which was quoted as 4% of keratinocytes on average [6] . Other authors pointed out that there were also cycling cells in rete pegs and ridges [7] [8] [9] [10] . Webb et al. [11] reported 7.71% for the stem cell compartment of neonatal skin basal layer, similar to 7.44% for skin basal layer in adults. From neonatal epidermis, Rachidi et al. used two membrane markers for enrichment of progenitor and stem cell populations, integrin a6 (ITGa6/CD49f) and transferrin receptor (TFRC/CD71). They found that progenitor cells (also called transit-amplifying (TA) cells) represented 10% of the total cell population and quoted 14.7% of cycling cells, whereas stem cells represented less than 1% of keratinocytes, with 1.9% cycling cells [12] . Those values showed the slower average cycling rate of stem cells than their daughter basal cells, and are consistent with $3 transit cell divisions in the basal layer before migration to the suprabasal layers of epidermis.
As they mature, keratinocytes move upwards to the spinous layer and then flatten out as part of the terminal differentiation programme that ends with desquamation in the horny layer. The body expends this effort to replace epidermis every month because the skin constitutes the first line of defense against dehydration, infection, injuries, temperature extremes and external radiations. As epidermis contains no blood vessels, epidermal homeostasis and the differentiation programme require factors diffusing from the dermis and partly provided by the circulation. The dermis also houses many of the skin functional components, including its vascular, neural and lymphatic systems, as well as epidermal appendages. These appendages include excretory and secretary glands (sebaceous, eccrine and apocrine glands), keratinising structures (hair follicles and nails), and sensory nerve receptors.
Hair follicle
Hair is a keratinised protein filament that grows through the epidermis from follicles deep within the dermis. It has two distinct parts, the hair follicle and the hair shaft. The bulbar region of the hair follicle contains a pool of relatively undifferentiated epithelial cells, termed matrix cells. During the growing phase of the hair cycle, or anagen, which lasts 2-8 years in the scalp, these matrix cells proliferate rapidly with a doubling time of 18-24 h. After this period of active growth, matrix cells cease to divide, and the lower follicle regresses during catagen (2-3 weeks). When regression is completed, the follicle enters telogen, a resting phase that can last for several years. The matrix cells then resume proliferation and produce a new hair bulb, thus reentering anagen and completing a hair cycle [13] . The hair follicle comprises many cell types, including mesenchymal cells and melanocytes, but the main cellular component is an epithelial lineage.
Adverse skin reactions to radiation

Radiation damage to normal skin
Skin is one of the most responsive tissues to IR, and particularly epidermis. Despite improvements in medical irradiation techniques [14] , skin changes can be experienced by up to 95% of radiotherapy patients [15] , and radiation toxicity cases are increasing after interventional radiology [16] . The radiation response of the skin has been documented extensively [6, 7, 17] . Exposure of the skin may lead to the development of several waves of erythema (reddening) of the skin. An early response (early transient erythema) is seen a few hours after doses of a few Gy, when the exposed area is relatively large, due to changes in vascular permeability. The main erythematous reaction, which begins after approximately 10 days, develops as a consequence of the inflammation secondary to the death of epithelial basal cells. The severity of clinical changes associated with epidermal hypoplasia depends on the size of the area irradiated. Severe hypoplasia is identified as moist desquamation. Irradiation will also inhibit the proliferation of matrix cells in the base of a growing hair: this may be transient, leading to hair thinning, or can produce alopecia or epilation, with the eventual regrowth of hair. However, hair loss may be permanent. Again, like epidermal hypoplasia, this reaction is seen within a few weeks of exposure. Hence, the skin response to radiation is typical of an early-responding hierarchical lineage, showing a dose-dependent level of expression and recovery, and a dose-independent response at high-dose when all stem cells are sterilised. The effects of dose fractionation, dose rate, area irradiated, dose recovered per day due to repopulation, have been well described [7, 18] .
The healing of moist desquamation, which depends on cell proliferation and the migration of viable cells, may occur very slowly after doses >8 Gy. Also, changes in vasculature, effects on fibroblasts, and varying levels of regulatory growth factors result in the potential for altered wound healing when radiation is given before or after surgery.
Small areas of human skin will tolerate higher doses than will large areas, mainly because of the ability of the epidermis at the edge of the irradiated field to repopulate and migrate over substantial distances during the recovery phase. In contrast, very high-doses, for example from "hot particles", can produce a unique response, referred to as acute epidermal necrosis, because of the direct interphase death of post-mitotic cells above the basal layer of the epidermis [7] .
Also, a cutaneous radiation syndrome (CRS) has been described in accident cases, and observed in particular after the Chernobyl accident [19, 20] . In 16 of the 28 individuals who died from the immediate consequences of radiation over-exposure related to this nuclear accident, the primary cause was attributed to CRS. Estimated total body doses ranged from 2.1 to 9 Gy, and local skin doses were considerably higher. The early signs of CRS range from erythema to blisters, exfoliations and ulcerations of the skin, alopecia, mucositis and conjunctivitis.
In radiotherapy patients, the analysis of complications in human cohorts is largely based on skin reactions and recorded Fig. 1 . Late epidermal complications in the skin of radiotherapy patients. The residual injury of RT can be skin hyperplasia, with acanthosis in epidermis and fibrosis in the underlying dermis, driven by chronic inflammation and deregulation of the TGF-b1 pathway. Immunohistochemistry staining of TGF-b1 (original magnification X40), involucrin and cytokeratin 14 (original magnification X20) on irradiated epidermis from a radiotherapy patient with epidermal hyperplasia versus a control epidermis from a non-irradiated donor.
according to the Common Terminology Criteria for Adverse Events (CTCAE) [21] and the Radiation Therapy Oncology Group (RTOG) [22] international scales. The most frequent late residual injury in skin after fractionated and high-dose irradiation is epidermis thinning, with fragility to any additional type of stress, favouring the development of late skin necrosis. On the contrary, the residual injury can be hyperplasia, with acanthosis in epidermis and fibrosis in the underlying dermis, driven by chronic inflammation and deregulation of the TGF-b1 pathway [23, 24] (Fig. 1) .
In humans, the most successful agents for reducing early reactions are anti-inflammatory compounds [15, 16, 25] . For the treatment of severe radiotherapy complications, corticosteroids and anti-oxidants have been used in clinics, and the combination of pentoxifylline/vitamin E appeared particularly successful to treat dermal fibrosis and epidermal acanthosis [26, 27] .
The effects of medium and high-dose of radiation on human skin have been well described. On the contrary, the effects of lowdoses, under 500 mGy, are poorly documented concerning adverse reactions, although human exposure to these doses is increasing through a variety of sources, including natural, medical, and occupational exposures. Initially, this low-dose range has been investigated at the cellular level. Microarray profiling showed that an acute dose of 10 mGy on cultured primary differentiated keratinocytes induced two waves of transcriptional responses, at 3 and 48 h after exposure, with a peak of response at 48 h [28] . Specific gene signatures from 3 to 72 h after 10 mGy were identified, as well as low-dose responsive promoter sequences. Another study using microarray analysis also showed a radiation response in confluent, quiescent keratinocytes at 4 h after exposure to 10 mGy, that appeared to be associated primarily with p53 targets [29] . To better reproduce the in vivo skin context, human three-dimensional (3D) skin models were further used. Exposure to 100 mGy protons resulted in disruption of differentiation and hypercornification, with micronucleus formation and specific gene expression profiles [30] . Three-D models also permitted the demonstration of bystander effects, for example, with a charged particles beam delivering 100 mGy in precise locations of a reconstituted epidermis and the quantification of micronucleus formation in non-irradiated areas [31] . As secreted soluble factors are important for non-targeted effects, mass spectrometry was used to characterize the global secretome of a 3D human skin tissue [32] . Specific patterns of secreted proteins were found in 30 and 100 mGy exposed conditions, with notably upregulation of ERP29, a protein from endoplasmic reticulum involved in epithelial-mesenchymal transition (EMT). Also, in a clinical setting for prostate cancer, investigations have established how keratinocytes of the interfollicular epidermis respond to daily exposures of low-dose fractions of radiation (0.1-1.1 Gy per fraction). Hypersensitivity after low-dose fractions was observed from the first week of treatment, with increased signaling of DNA damage (gH2AX foci) and reduction of keratinocyte number, that persisted throughout the treatment course [33, 34] .
In conclusion, all these studies point out that one single lowdose radiation can impact a normal epithelial cell homeostasis, although the functional consequences of this low genotoxic stress remain to be further investigated.
Individual sensitivity to skin reactions
There is evidence for a variation in sensitivity to skin reactions among the human population. A good example is the detailed study of skin telangiectasia grading in a cohort of breast cancer patients treated with bilateral fields [35, 36] . The variations between responses in left and right-sided fields of the chest wall were analysed for each patient, as well as the variations in response to radiotherapy (RT) between individual patients. A strong correlation was found between left and right field responses, although they received different dose fractionation schedules, but large differences in responsiveness were found between patients, despite small variations in total dose. After testing different verifiable factors (e.g. radiation skin dose, menopausal status, chemotherapy and hormonal treatment) it was calculated that patient-related factors (i.e. genetic and epigenetic), could explain 81% to 90% of the patient-to-patient variation in skin telangiectasia level at 10 years after treatment, with the remaining 10% to 19% being random effects [36] . This association of the genetic component with risk of adverse reactions after radiotherapy has been reviewed in some detail [37, 38] . ATM is an extreme example of a single gene mutation markedly affecting tissue radiosensitivity. Three A-T (ataxia telangiectasia) homozygote children were reported to show unusually severe responses to cancer radiotherapy, particularly with respect to skin reactions [37, [39] [40] [41] . The ATM gene product is known to be involved in sensing double-strand breaks and activating DNA repair-related proteins, and radiosensitisation by $3 fold was reported in ATM À/À cell lines and knockout mice [42] .
Also, a 44-year-old patient with a milder form of A-T due to biallelic ATM mutations, but with some retained ATM kinase activity, received conventional radiotherapy for breast cancer. Posttreatment, an acute radiation reaction at the severe end of the normal spectrum developed, followed by a late reaction manifest as shrinkage and deformation of the breast, and considered to be due to the ATM mutations [43] . ATM heterozygous carriers are considered generally to be much closer to wild-type than to homozygotes regarding radiation toxicity. However, a study of candidate single nucleotide polymorphisms (SNPs) for cutaneous telangiectasia, drawn from telangiectasia-predisposing conditions, revealed an association between haplotypes of ATM and risk for telangiectasia, fibrosis, and two measures of combined toxicity in 388 breast cancer patients who received radiotherapy [44] . Also, recently a significant correlation was reported between the grade of radiotherapy complications and the maximal number of nuclear phosphorylated forms of ATM protein in irradiated skin fibroblasts derived from patients with 3 over-reacting severity grades [45] , independently of tumour localization and the nature of the reactions in normal tissues. There are also occasional reports of other radiosensitive patients, for example with the dyskeratosis congenita syndrome, a very rare telomere biology disorder, but the mechanism in that case is not known [46, 47] . For the vast majority of patients there is evidence for a fairly marked spectrum of radiosensitivities among them, including less than 1% of highly-sensitive and over-reacting individuals [38] .
Classical genetics, molecular studies of candidate genes or functional assays may help in developing new predictors of response to IR. For example, the TRAIL gene, which regulates human T4 lymphocyte apoptosis, was shown to be useful for the prediction of radiation-induced dermatitis in breast-cancer patients [48] . Also, assessment before radiotherapy of radiationinduced apoptosis in CD8 T-lymphocyte significantly predicted the risk of breast fibrosis in 502 breast-cancer patients [49] . Screening tests before radiation delivery using functional assays based on ATM phosphorylation in skin cells or lymphocyte apoptosis may help in the future to better tailor individual radiotherapy prescriptions. There is now a general trend towards investigating such variations in response using genome wide association studies (GWAS), and 'omics approaches', with a view to predictive testing of individual patient responses to therapy [50] [51] [52] [53] . These studies use databases of radiotherapy complications, which are recorded by clinicians according to international scales, largely on patient skin reactions. Those whole genome studies investigated genetic variants that could be associated with a risk of radiotherapy side-effects in more-homogeneous cohorts, notably concerning ethnicity and tumour tissue-specific location. For example, specific SNPs associated with radiation toxicity were evaluated in a two-stage design of breast cancer patients (2 then 6 cohorts including 2636 patients in total) and a meta-analysis approach pointed to a polymorphism in XRCC1 that could be used as a predictive test of toxicity [54] . On the other hand, a list of variants, known to increase the risk of breast cancer, was analysed in a one-stage study (3 cohorts including 1160 patients); these variants were not found correlated with an increased risk of radiotherapy toxicity [55] . Similar researches were performed in patients with prostate cancer. A three-stage whole genome study (3 successive cohorts including 1742 patients) identified TANC1 as a susceptibility locus for late (up to 5 years) radiotherapy toxicity [56] . In the same cohorts plus another (making a total of 1560 patients), variants associated with the risk of prostate cancer were not related to an increased risk of late (2 years) radiation toxicity [57] .
Therefore, more studies are necessary to uncover more SNPs associated with toxicity in homogeneous cohorts and for a wider range of tumour types, and later on in different cohorts set up to investigate other parameters, including ethnicities and various individual factors. Another novel approach may be the characterization of non-mutational processes, collectively known as epigenetic effects, that includes DNA methylation, chromatin modification and modulation of non-coding RNA expression, which could reveal new key regulators of human radiosensitivity.
Skin carcinogenesis
Skin cancer is separated into two categories, melanoma and non-melanoma skin cancers. There is no evidence that IR exposure can increase melanoma incidence, so this review will focus on basal and squamous cell carcinoma, as they constitute the major types of skin cancer as well as being radiation-related tumours in skin.
Basal cell carcinoma (BCC)
BCC of the skin is the most common malignant neoplasm in humans [58] , accounting for about 90% of all skin cancers, and its incidence is increasing worldwide [59] . Despite this high frequency, the death rate from BCC is very low, because these tumours rarely metastasize. BCC, which arise from epidermal keratinocytes, are mostly localized tumours, but their capacity for local invasion can cause disfiguring and destruction of skin. Infrequently (<0.1% of cases), metastases can develop regionally in lymph nodes or at sites distant from the primary tumour, in the lung, bone and internal organs. The principal etiologic factors include UVR and IR, chemical carcinogens (arsenic, PAH, psoralens) and possible infection with papilloma viruses. Sunlight is a major environmental factor for BCC development, as demonstrated by the fact that mutations are frequently UVR specific.
Concerning the molecular mechanisms of development of this cancer type, the only molecular abnormality known for a long time was TP53 mutations, which are found in 61% of sporadic BCC [60] . Identification of a genetic event in a rare subset of patients who have a great propensity to develop BCC pointed to aberrant Sonic Hedgehog (SHH) signaling as one of the pivotal defects leading to formation of these tumours. This rare heritable disorder is the Gorlin syndrome (also known as basal-cell nevus syndrome, BCNS) which is caused by mutations in the PTCH1 gene, encoding the receptor to which the SHH ligand binds [58, 61] . The incidence of this syndrome ranges from 1/56,000 in UK to 1/235800 in Japan and 1/256,000 in Italy [62, 63] . Aberrant activation of the SHH pathway has been observed in sporadic and hereditary BCC [64] . Mutations in at least one allele of PTCH1 have been identified in 90% of sporadic BCC. Loss of PTCH1 function can be mimicked by overexpressing the Sonic Hedgehog protein ectopically in regenerating human skin, thereby inducing development of BCC features in human tissue [65] . Grafting an in vitro reconstituted human skin sample in immunodeficient mice requires high cell proliferation at several steps. This might explain why this model allows obtaining within months what requires years in human skin. In vivo, in undisturbed skin with a slower turnover, and after more moderate activation of the SHH pathway, a much longer latency period is required for BCC induction. Similarly, skin tumour development in mice can be obtained by the overexpression of other members of the SHH pathway, either normal or mutated [66] [67] [68] . Those studies suggested that a single genetic alteration can induce BCC development by triggering a major cancer pathway [69] . Recently, a genomic analysis on 263 sporadic BCC and 30 tumours from patients with Gorlin syndrome confirmed that 85% harbored mutations in the SHH pathway (with 73% in PTCH1) [60] . Then, overactivation of SHH signaling is a key event to induce the development of the most common cancer (Fig. 2) .
Due to the fact that BCC are slow-growing and poorly metastatic tumours, their genomes have long been thought to be relatively stable, with a limited number of mutagenic events. However, some studies proposed that other recurrent genetic aberrations were operating [70] , which has been recently confirmed by the genetic study of a large BCC cohort [60] . Actually, besides the numerous mutations in the SHH pathway, genetic profiling of this cohort found also 85% of the BCC harbored additional driver mutations, notably in MYCN (30%), PPP6C (15%), and STK19 (10%), and loss-offunction and deleterious missense mutations were present in PTPN14 (23%), and RB1 (8%). Importantly, the authors found that BCC harbor the highest mutation rate in cancer (65 mutations/Mb), which might explain the high phenotypic variation observed for these tumours. Although the majority of BCC arise sporadically, genetic factors may also have a substantial role. Several genetic diseases are associated with the development of skin cancer, including xeroderma pigmentosum and Gorlin syndrome. Apart from genetic diseases, very little is known about population genetic susceptibility to BCC. In contrast to Caucasian populations, persons of the South Asian and African ancestry with dark skin colour are resistant to BCC development. SNP technology was used to characterize DNA sequence variants that confer susceptibility to cancer. Some of these variants seem to operate through their association with fair-pigmentation traits, resulting in reduced protection from the damaging effects of UVR [71, 72] . Other sequence variants, such as keratin 5, have no obvious role in pigmentation or UVR susceptibility but instead seem to operate in the contexts of growth and differentiation of the basal layer cells of the epidermis [73] . SNPs were also found in inflammatory and immunity genes, known as key factors of non-melanoma skin cancer etiology [74] .
Squamous cell carcinoma (SCC)
Similar to BCC, SCC also arises from epidermal keratinocytes, but SCC is a more aggressive tumour that can form lethal metastases. Approximately between 180,000 and 400,000 patients per year develop skin SCC in the United States [75] . Although skin SCC is often cured by surgical excision, 8% of patients with skin SCC relapse, and 5% present metastasis within 5 years. In patients with metastatic SCC, the prognosis is very poor, with only a 10-20% survival rate over 10 years [76] . Sunlight is clearly the major environmental factor for SCC development. The incidence rises with the total number of hours of sun exposure [77] and the use of sunscreens correlates with reduced SCC risk [78] , even in the long term [79] . In the medical field, a high risk of SCC is well documented in organ transplanted patients [80] . This risk is not found for other skin cancers, and it appears primarily driven by immune suppression. Spontaneous SCC are associated with several genomic aberrations and mutations, including RAS, TP53 and p16 (CDKN2A) as the most studied genes. The RAS GTPase is mutated to an activated form in 20% of sporadic SCC. RAS is also strongly activated biochemically in its GTP-bound form in most human SCC through additional mechanisms besides direct RAS mutation. Such mechanisms might include RAS gene amplification, overexpression of upstream receptor tyrosine kinases, or loss of inhibitory microRNAs. Whereas RAS mutations seem to be an early step in skin cancer initiation, TP53 mutations are associated with malignant progression. In addition, c-MYC over-expression and activation of STAT signaling occur frequently in skin SCC development, notably playing a role in the progression to the malignant state. Recurrent mutations in 19% of cutaneous SCC were also found in the kinetochore gene KNSTRN [81] , a gene involved in chromatid cohesion anomalies, which correlated with tumour aneuploidy. A recent and broader study compared different types of SCC by nextgeneration sequencing and highlighted alterations in a set of 7 genes (TP53, PIK3CA, CDKN2A, CCND1, SOX2, NOTCH1, and FBXW7), which were defined as common to all types of SCC, including cutaneous cancers [82] .
SCC arises most commonly as a sporadic tumour, but it is also characteristic of several inherited disorders, including those that impair DNA repair and genomic stability, such as xeroderma pigmentosum and dyskeratosis congenita, in which SCC might arise as a secondary result of increased genomic mutagenesis. SCC also affects approximately 75% of patients who are afflicted with recessive dystrophic epidermolysis bullosa. In summary, SCC is a skin tumour that differs from BCC in many respects, including the etiology, genetics, incidence rate and pathology.
Some other rare skin tumour types have also been described, such as trichoblastoma and trichoblastic carcinomas, which are tumours with differentiation towards hair structures [83] .
Radiation carcinogenesis in human skin
Cancer types and threshold doses
The first type of cancer documented as being associated with exposure to IR was skin cancer, which was reported only 7 years after the discovery of X-rays [84] . IR is a general risk factor for workers, as described by the European HELIOS study performed for 10 major occupational groups [85] . Radiation-induced tumours in skin are mainly carcinomas, developing from keratinocytes of the Fig. 2 . Different genes and pathways involved in BCC development. The involvement of Sonic hedghog signaling pathway is well described in basal cell carcinoma. SHH binds to its receptor PATCHED1 to activate the pathway. This binding allows the derepression of the Smoothened protein (SMO) leading to the activation of the GLI transcription factors (in green) that target genes involved, but no restricted to, cell cycle, migration and survival. The Suppressor of Fused (SUFU) is a negative regulator of GLI which modulates the nuclear-cytoplasmic transport of GLI1. In the absence of ligand, PATCHED1 maintains SMO under an inactive form. The HIPPO pathway regulates cell proliferation, differentiation and cell death through YAP that acts as a transcriptional regulator, and members in RTK-RAS-PI3 K pathways are also involved in these processes. Mutations in members of those pathways can either lead to a gain-of-function (in red) or loss-of-function (in blue).
basal layer of epidermis, with a latency period considered to be at least 20 years. An association between low-LET external exposures and the risk for these non-melanoma skin cancers has been demonstrated in a series of studies, based on accidental and medical treatment data [86] [87] [88] . No significant relationship of melanoma with IR exposure has been demonstrated, including in the Japanese cohort of atomic bomb (A-bomb) survivors [87] , as well as no evidence of a dose response [89] .
BCC are the more frequent type of skin radiation-related tumour and elevated risks of radiation for BCC remains more than 50 years after exposure [89] [90] [91] . Induction has been well documented, and it has been reported after occupational, therapeutic and accidental exposures [7, 17, 92, 93] . In the survey of Japanese A-bomb survivors for the time period 1958-1987, a strong positive dose-response was reported for BCC at high-doses, with an estimated threshold of 1 Gy and an excess relative risk (ERR) of 4 above 1 Gy [91, 94] . This Life Span Study (LSS) cohort is very informative because skin cancers are relatively rare in Japan. In 1995, BCC incidence has been estimated from a few rare cases to be around 16 per 100,000 [95] . These rates are much lower than in the US Caucasian population (around 600 for BCC and 100 for SCC per 100,000 in 1994) [96] . The LSS survey for the time period 1958-1996 included a higher number of cancer cases, and the best fit dose response for BCC showed an excess risk significant above about 0.6 Gy, with no dose trend below that, with an ERR value of 2.2 at 1 Gy [89] . Thus the current A-bomb survivor data indicate that BCC can be significantly induced above about 500 mGy by an acute exposure at moderate doses and high-dose rate, with little cancer risk at lower doses. Medical exposures also documented the cancer risk. In the tinea capitis cohort studies in New York and Israel, significant BCC development after medical irradiation of the scalp was demonstrated [93, 97] , with further confirmatory evidence from a large population-based case-control study [98] . In different studies of the effects of medical exposures, where mean doses ranged from 2.25 to 6.8 Gy, the mean relative risk per Gy was estimated at 1.6 (1.1-2.1) [99] . In a study of skin cancers induced by radiotherapy in childhood, BCC were strongly induced within the radiation field by therapeutic doses ranging from 7 to 27 Gy [100] . Similarly, the Childhood Cancer Survivor Study reported that a significant dose response at doses greater than 1 Gy was found for 199 cancer survivors who had received radiotherapy in the United States [101] . An increased risk was also demonstrated for adults after radiotherapy, after classical protocols using multiple doses of 2 Gy per fraction, with tumour development confined to the site of exposure [102] .
Induction of SCC by IR has been much less documented than for BCC. The proposed ratio of radiation-induced BCC/SCC incidence is generally 10:1, but it varies according to the particular study. In the LSS survey for the time period 1958-1996, a significant dose response was observed for SCC in situ (ERR of 0.71 at 1 Gy) but not for invasive SCC. For early radiation workers, who frequently had high and chronic exposures to their hands, there were numerous reports of SCC [103] . A population-based study among men in Alberta, Canada, reported a 5-to 6-fold increase in incidence of BCC and SCC associated with non-diagnostic x-ray exposure [104] . Another study performed in New Hampshire showed that an increased risk of both BCC and SCC was found in relation to therapeutic IR [98, 102] . Elevated risks were confined to the site of radiation exposure (BCC odds ratio, 3.30; SCC odds ratio, 2.94). Thus SCC can be induced significantly only by high radiation dose [105] . A mortality rate of 1% was evaluated for SCC [7] .
As radiation-induced skin tumours are very similar clinically to sporadic skin tumours, IR appears essentially to increase the natural rate of BCC and SCC. Since radiation is associated primarily with BCC, mortality from radiation-induced skin cancer is extremely low. The case-fatality rate for BCC is about 0.05%, i.e., about 1 in 2000 who develop BCC dies of it [106] . Importantly, none of the main epidemiologic studies of skin cancer in irradiated populations has shown a statistically significant excess of malignant melanoma [99] .
Individual factors of risk variations
Several studies have examined how risk varies by age at radiation exposure. In the A-bomb study, there was a 30-fold variation in excess relative risk for BCC with age of exposure [94] . The excess relative risk was 21 for those aged 0-9 years at exposure and 0.7 when exposed at ages higher than 40 years. In a later analysis, the risk also decreased rapidly with increasing age at exposure but there was little change with attained age [91] . In the case of tinea capitis, an Israeli study [97] and a New York study [93] showed clear age effects. The declines in risk amounted to 11% per year of age at exposure in the A-bomb study, 13% in the Israeli study and 13% in the New York study. A similar strong relation between BCC induction and radiation exposure in childhood was also shown in a study of secondary skin neoplasms in long-term survivors from cancer [101, 107, 108] . Thus, the available studies show that skin cancer risk is greater from radiation exposure at younger ages than at older ages [99] . Another possible factor of individual variation in risk is gender. For sporadic BCC in humans, male gender is a known risk factor and is associated with more BCC than in females (ratio 2.1). Although the role of estrogens in the development of skin cancer is controversial, the results point to a protective effect of hormonal status on BCC development. Also, the incidence of BCC in sun-exposed sites is significantly higher in men than in women [109] . However, for radiation-induced skin cancer, none of the major studies had found a significant difference in cancer risk according to gender [99, 110, 111] . In the initial description of skin cancer in the Japanese survivor cohort, no gender effect was observed in the incidence of radiation-induced BCC at nonexposed sites among the survivors [112] . However, the last LSS survey, analyzing the time period 1958-1996 with a higher number of cancer cases, pointed to a gender difference, as the crude incidence rate for males exposed to more than 1 Gy (35.7 per 10 5 person-years) was 1.8 times higher than that for females. There was still no significant difference in crude incidence rates of BCC between males and females exposed to less than 1 Gy [89] . Another factor of individual variation in skin cancer risk is pigmentation. In the tinea capitis study, the skin cancer radiation risk was 10 times lower among African-Americans than among Caucasians [93] . Thus the protection by pigmentation appears to occur both for sporadic and radiation-related tumours.
Interaction with UV
An interesting biological question is whether UVR and IR have an interactive effect on skin tumour induction. The initial study of Abomb survivors concluded that the excess risk per Gy was higher on UV-shielded skin than on the face and the hands [94] . Another study of the same cohort showed that the excess absolute risk of BCC per unit skin surface area did not differ between UVR-exposed and shielded parts of the body, suggesting a simple additivity of the UVRrelated and background BCC risks [110] . The last analysis of the LSS survey, reporting on the time period 1958-1996, did not result in further progress, so that it was proposed that a further follow-up was needed to assess the nature of the UVR and IR interaction more precisely [89] . Mizuno et al. assessed the association with UVR in BCC from this Japanese cohort, by characterizing mutations in the TP53 gene. They showed that 70% of BCC had TP53 mutations independent of IR or UVR. However, the distribution of mutation types depends on the UVR or IR exposure, suggesting different modes of action of IR and UVR in inactivating this gene [113] .
After medical exposure, studies of patients irradiated for tinea capitis reported contradictory results, with relative risk greater on the relatively UVR-shielded scalp than on the face and neck [97] , or greater for the UVR-exposed margin of the scalp (21/100 cm 2 per Gy) than for the (relatively) UVR-shielded scalp (4.7/100 cm 2 per Gy) [93] . In a study of second skin neoplasms in patients surviving from childhood cancer, all the BCC were located within the radiation field, thus indicating that IR is the key aetiological factor, even in the absence of any meaningful interaction with UVR [107] . Thus, no clear evidence appears after accidental or medical exposure for an interaction between IR and UVR exposure. However, there is some evidence for an association of IR sensitivity and UVR susceptibility. A New York study of IR treatment for scalp ringworm found a substantial excess of BCC among white patients but no skin cancer among the irradiated black patients [103] . The radiation risk for skin cancer was 10 times higher among the Caucasians. For SCC, an association with radiotherapy was principally observed among persons with a sun-sensitive phenotype [98, 102] . Finding few excess skin cancers among irradiated African-Americans as compared to Caucasians with a comparable dose may indicate that skin susceptibility to UVR exposure increases the excess risk from IR. Thus the question of a possible interaction between IR and UVR remained unresolved, and more data were considered necessary to fully understand this complicated relationship [114] .
Genetic susceptibility to radiation-induced skin cancers
For most genetic diseases associated with a predisposition to radiation-associated cancer, no particular susceptibility to nonmelanoma skin cancer has been described, even though increased intrinsic cellular radiosensitivity has been reported for several of them in skin fibroblasts. For example, ataxia telangiectasia patients, in which fibroblasts exhibit an unusual sensitivity to radiation, do not show any excess of IR-induced skin carcinoma. However, for several of these diseases with premature death of the patients, skin carcinoma may not be observed simply due to the long time required for the growth of this type of tumour.
Evidence for a correlation between radiation exposure and increased risk in skin cancer due to genetic susceptibility comes thus mainly from studies of patients affected by Gorlin syndrome [62] . This rare autosomal dominant disease is characterized by a wide range of developmental abnormalities and a predisposition to develop tumours, particularly BCC. In Gorlin patients, BCC usually starts at puberty, and up to 90% of patients will have developed a BCC at the age of 40 years. For black Gorlin patients, the incidence of BCC is lower (40%) and occurs at later ages, probably linked to protection due to skin pigmentation. After radiotherapy for medullablastoma in children with Gorlin syndrome, multiple BCC were found in the radiation field at 3-6 years after irradiation [115] [116] [117] . Intrinsic fibroblast sensitivity to low-LET radiation exposure has been reported by some authors [118, 119] , but not by others [120, 121] . Further studies need to be done to clarify these discrepancies. Similarly, data on Gorlin cell sensitivity to UVBinduced cell survival are contradictory [122, 123] .
Susceptibility to BCC may be modulated by other factors than PTCH1 mutations. Thus, in Ptch1 +/À mice crossed with different genetic backgrounds, it has been shown that the sensitivity to radiation-induction of BCC is modulated by many other genes enhancing or inhibiting BCC tumourigenesis [124, 125] . Those studies highlight the fact that patients with the same mutation can have different phenotypes due to environmental factors but also to genetic background that can modify the tumourigenesis progression or tissue specificity. Further studies focusing on genetic and epigenetic analysis from radiation-induced BCC compared to surrounding normal tissue would be necessary to better understand the molecular bases of BCC induction.
Another interesting question is the possible specific signatures of radiation-induced tumours. Until now, genetic analyses of BCC after irradiation have not provided such signatures, even in the PTCH1 gene. It would be thus relevant to this question to characterize by next generation sequencing skin carcinoma developed in the Japanese A-bomb survivors, to elucidate major new mechanisms of carcinogenesis and bring knowledge on the possibility of specific signatures. Deriving iPS cell lines from patients with hypersensitive syndromes such as Gorlin syndrome could help better understand the development of radiationinduced skin tumours. However, this approach was found disappointing, as dedifferentiation to pluripotency requires efficient DNA repair capacities, which are deficient in most genetic diseases of radiosensitivity. The more recent description of techniques permitting genome editing appears a better approach. Modeling human radiosensitive diseases could be obtained by modifying specifically normal human cells on targeted genes and non-coding regulatory sequences using CRISPR/Cas9 technology, and this will be possible on selected cell populations. This strategy is fast-growing and the proof of principle of its feasibility has been recently obtained in Fanconi anemia patient-derived fibroblasts harboring a homozygote point mutation, leading to a decrease in DNA repair capacity [126] . Transfection of the CRISPR/Cas9 system allows repair of the gene and leads to gene expression with no active off-targets. The feasibility in human keratinocytes has also been documented, as electroporation of CRISPR/Cas9 plasmids into keratinocytes resulted in the stable knockdown of NUMB, a gene involved in asymmetric cell division [127] .
Skin stem cells
Several types of epithelial precursors and stem cells have been described in skin, including those from epidermis, sweat gland, hair follicle and sebaceous gland. These distinct epithelial stem cell populations self-renew and generate cells with unipotent or multipotent differentiation potential [128] . Skin homeostasis depends on the maintenance of these stem cell pools, as well as skin regeneration after wounding. Also, as stem cells self-renew during the whole life of an individual, genomic instability is a potential major issue concerning skin cancer. Epithelial stem cell populations possibly involved in tumour development will be discussed, as well as their responses to IR and the possible mechanisms that they use to maintain the stability of their genome.
Stem cells from interfollicular epidermis
The presence of a stem cell reservoir in epidermis was conceptually proposed in the 1970s [3, 129] . The functional demonstration of the presence of such regenerative cells was obtained through the development of in vivo microcolony assays, first in mouse dorsum [130, 131] , then in pig flank [132] . In human chest wall, macrocolonies of epithelial cells developed in skin of radiotherapy patients after skin desquamation [4] . The first treatments of skin burns using cell therapy also demonstrated functionally the presence of skin stem cells, when a permanent coverage of large burn wounds was obtained with autologous cultured human epithelium [1, 2] . Keratinocyte stem cells from epidermis form the major regenerative reservoir in human skin, and their general characteristics can be defined as:
-rare cells in epidermis and the only permanently resident cells, found in well-protected niches of the basal layer in a specific micro-environment. -immature cells, with specific programmes of gene expression and epigenetic patterns.
-slow-cycling cells in homeostatic conditions.
Functionally, stem cells are responsible for keratinopoiesis and the long-term maintenance of skin, thanks to their self-renewal potential, i.e., their capacity to proliferate through asymmetric division and remain in an undifferentiated state. Thus the entire epithelial lineage and ultimately the tissue are dependent on this stem cell reservoir. Stem cells also regenerate skin after wounding, as they are capable of very high proliferation in response to wounding and to certain growth stimuli. This regenerative capacity is triggered following injury, culture or transplantation.
In human epidermis, a hierarchical organization of the basal layer has been proposed, where rare stem cells give rise to keratinocyte progenitors (Fig. 3) . These progenitors, also termed transient-amplifying keratinocytes, are responsible for the shortterm maintenance of the skin, as they divide frequently and then migrate to the suprabasal layers to give rise to the differentiated keratinocytes.
An important step in the characterization at the cellular level of keratinocyte stem cells was obtained in tissue culture by discriminating functionally three clonal types of keratinocytes from human interfollicular epidermis, with different capacities for multiplication, namely holoclones, meroclones and paraclones [133] . Holoclone keratinocytes are the progeny of a single cloned stem cell. Their extensive growth potential in tissue culture is such that the entire epidermis of a human adult (estimated at 1.4 Â 10 11 nucleated keratinocytes [134] ) could be generated from the progeny of a single holoclone. Indeed they generally undergo more than 100 cumulative population doublings while maintaining genomic stability, and functionally they maintain their potential for organogenesis and epidermis reconstruction at least up to 50 doublings [135] . The concept of holoclones is thus widely used as a criterion for human epidermal stem cells, in both fundamental biology and clinical use.
Defining specific markers for keratinocytes according to their differentiation state is an approach which has been used extensively to purify skin stem cells. Although a variety of membrane markers have been described for basal keratinocytes, there is still no unique marker to identify precisely these cells in vivo in human skin, for example on a tissue section. However, several methods have been described that can successfully select cell populations which are enriched for stem cells from human epidermis, including selection by flow cytometry sorting on cell size [136] , specific membrane markers, and drug exclusion [9, 137, 138] .
A functional assay based on cell metabolism has been demonstrated as an efficient method of stem cells isolation from primary keratinocyte cultures, as a family of drug-effluxing pumps, including the BCRP1/ABCG2 transporter, allowing the exclusion of DNA dyes such as Hoechst 33342, is more active in stem cells. The small Side Population (SP) of cells that is able to rapidly exclude the dye, is enriched for stem cells [139] . SP keratinocytes represent 0.16% of the total population, exhibit increased colony-forming efficiency and long-term expansion potential as compared to other keratinocytes, and retain the potential to form a pluristratified epidermis even after long-term culturing [140] .
Combinations of markers based on two major stem cell properties, quiescence and strong adhesion to the basal layer of epidermis, constitute the most widely used selective method. High expression of adhesion molecules like integrins is common to most adult stem cells [141] revealed that the quiescent a 6 bri /CD71 dim fraction was the most potent proliferative and tissue regenerative population of the epidermis, capable of long-term epidermal renewal from as little as 100 cells for up to 10 weeks [145] . Moreover, this integrin a6/CD71 strategy was the only one for which serial transplantation potential in immuno-compromised mice could be demonstrated for primary cells [146] . All these results support the model in which the epidermal proliferative compartment of human skin is not composed of equipotent cells, but rather is organized in a functionally hierarchical manner with the most potent quiescent stem cells at its apex followed by cycling progenitors and finally early differentiating keratinocytes. Using a novel multi-epitope ligand cartography approach of human epidermis, these markers were confirmed and further extended to a combination of seven proteins that may characterize epidermal stem cells, including immaturity markers (p63 À ); these cells represented 6% of all basal keratinocytes [147] . The hierarchical organization of keratinopoiesis from the basal to suprabasal layers of epidermis has been investigated in mouse skin. Functional grouping of keratinocytes representing the lineage of a single stem cell in the whole epidermis has been demonstrated, and termed the epidermal proliferative unit (EPU) [148] . Such structures have been searched for in human epidermis by grafting human foreskin samples onto nude mice. Six weeks later, viruses encoding eGFP were injected intra-dermally into the grafted skin, resulting in persistent transgene expression over 28 weeks. This strategy allowed demonstration of the presence of EPUs in human epidermis [149] , and revealed that there was no preferential site of origin in the basal layer, as the EPUs originated from the top, sides and base of rete ridges as well as from relatively flat regions of the basement membrane. The number of basal cells in an EPU cross-section was variable; however, more than 78% of EPUs in this region were between 1 and 4 cells in diameter suggesting that at least 10% of basal cells in these areas are stem cells, similar to the situation in mice described above. The data suggested that stem cell progeny follows a path perpendicular to the surface of the epidermis regardless of the stem cell position in the rete ridge. Such organization may be necessary to overcome structural complexity associated with the abrupt change in the orientation of the undulating human basal layer.
Stem cells from hair follicles
Stem cells from hair follicles have been well characterized in rodent skin, due to their importance in these species and the existence of specific structures like the bulge [150] . In contrast, the composition of stem cells in the human hair follicle (HF) is still largely elusive, and large differences exist in the two species, for example in the cycling time, as murine HFs regenerate every 4 weeks, whereas human HFs may rest in the stationary or telogen phase from 2 to 8 years, but also stay in an active phase of growth for 2-7 years, for example in the scalp. In human skin, although several lines of evidence have suggested that the hair follicle also provides a niche for keratinocyte stem cells, anatomic boundaries, biochemical distinctiveness, and global gene expression pattern are ill defined. However, studies of label-retaining cells indicated that human hair follicle stem cells were located in a specific area of the hair follicle [151] . These cells were subsequently isolated and characterized as slow-cycling and expressing markers such as b1 integrin, CD200, KRT15, and KRT19 [152] . Transcriptional profiling of human bulge cells has revealed similarities but also important distinctions between mouse and human bulge cells [153] . Interestingly, a role has been proposed for SHH signaling in maintaining the human "bulge" cell phenotype in young and aged human skin [154] . Although it has been shown that under severe stress conditions some of these stem cells can undertake a variety of restorative-related functions, their role in homeostasis as yet is poorly described.
Transcription and epigenetic factors regulating epithelial stem cell state
Stem cell identity and functions depend on both extrinsic factors, notably components of the niche, and cell-intrinsic factors. The intrinsic regulators include transcription factors and epigenetic regulators which control transcriptional networks to drive tissue-specific gene expression patterns.
The superfamily of transforming growth factor-bs (TGF-bs) represent a major type of extrinsic factors, that constitute general components of the intercellular crosstalk between many types of stem cells and their microenvironment [155] . For human keratinocyte stem cells, the dosage of TGF-b1 growth factor is critical, as an anti-proliferative effect is observed when the factor is present at high concentrations (more than 100 pg/ml), whereas extremely low but physiologically relevant doses of TGF-b1, in the range of 10-30 pg/ml, promoted cell amplification, associated with a higher maintenance of the immaturity markers a6 and b1
integrins [142] . The FGF family is less characterized, although the FGF2 protein may play an important role in keratinocyte stem cell biology [156] . SHH signaling is a regulator of epidermal stem cells in mouse hair follicles. In human fetal skin, several members of the pathway are expressed, including the PATCHED1 receptor and the GLI1 transcription factor, and may regulate stem cell proliferation, as fetal stem cell growth is stimulated in vitro by SHH, and conversely decreased by cyclopamine [157] .
The WNT/b-catenin pathway is an intrinsic regulator which has been well characterized in mouse skin because it is essential for hair follicle development, but little studied in human skin. On human skin sections, b-catenin expression was found decreased in the most immature cell population [147, 158] , which suggests that the pathway may be down-regulated in quiescent stem cells, whereas the switch to an activated state was associated with increased expression in the most clonogenic cells in tissue culture, when stem cells are in an activated state [159] .
Distinct polycomb complexes can balance epidermal stem cell dormancy and activation. Thus CBX4, a protein associated with PRC1, maintains human epidermal stem cells as slow-cycling and undifferentiated. Moreover, when these cells were CBX4-depleted, they failed to reconstitute a homeostatic epidermis in vivo [160] . CBX4 acts notably through its SUMO ligase activity, repressing factors such as EZH2, DNMT1, and BMI1 to prevent the stem cells entering an active state.
Recently, the epithelial stem cell epigenome has been shown to contribute to the fine-tuning of the transcriptional networks, which ultimately shape and maintain the stem cell compartment. This epigenome is controlled by the dynamic regulation of the expression, activity, and localization of proteins involved in DNA methylation, histone methylation and acetylation, and chromatin remodeling [161] . The enrichment of DNA methylation in keratinocyte progenitors is particularly over-abundant in promoter regions of lineage-specific differentiation genes, and thus DNA methyltransferases are enriched in undifferentiated epidermal progenitors and are necessary to sustain their proliferation and repress differentiation, as found for DNMT1 [162] and DNMT3b (MT Martin, unpublished data).
Another emerging class of stem cell regulators comprises noncoding RNAs. Thus ANCR (Antidifferentiation Non Coding RNA) provided the first example of an LncRNA that controls the differentiation state of a somatic stem cell [163] . Specifically, ANCR depletion results in ectopic differentiation of epidermal stem cells, implying that its role is to suppress the differentiation pathway in the epidermis and maintain the stem cell compartment.
Many other regulatory factors have been described that control the transition between keratinocyte stem cells and their more differentiated progeny, as well as the migration of basal keratinocytes to the suprabasal layers of epidermis, including p63, NOTCH or TINCR. Impairment of these transitions may be important concerning the long-term effects of acute and chronic low-doses of radiation in skin.
Radiosensitivity of stem cells and progenitors
Intrinsic radiosensitivity
The idea of stem cells being the target cells for early skin reactions to radiation was promoted by the development of in vivo colony techniques, first in mouse dorsum [131] , then in pig flank [132] . In two patients receiving different multiple dose fractions per day, the macro-colony technique in chest wall also provided the first evidence of some cells surviving high-doses of radiation and producing nodules of new epidermis by 2-3 weeks after radiotherapy, which would re-epithelialize otherwise denuded areas, and assumed to be precursor keratinocytes, i.e. stem cells and progenitors [4] . At that time, the radiosensitivity of those cells in humans had not been determined accurately in vivo because of the difficulties involved.
Various animal systems have been used to show that doses of !10 Gy were needed to induce measurable levels of pyknotic cells in the basal layer of epidermis. In mice, reported levels were only 1-10% of basal cells up to 14 days after irradiation, with a reduction in basal cell density by 5-8% per day independent of dose over 17-50 Gy. No change in the migration rate and labelling index were found in the basal layer after 12 Gy compared to non-irradiated mice [6] . Hence it was proposed that the irradiated transit cells may be able to continue to do 1-3 divisions, then differentiate and migrate towards the surface, so contributing to the latency period before desquamation reactions appeared. Changes in the proliferation kinetics of pig epidermis, considered the closest model used to human epidermis, were studied after irradiation with a dose fractionation regime used routinely in radiotherapy (30 fractions in 39 days, total X-ray doses of 52.3 Gy, 61.5 Gy, 70.7 Gy and 80.0 Gy) [164] . The irradiated epidermis exhibited an initial degenerative phase, during which the rate of basal cell depletion was independent of dose and would be due to normal migration with reduced renewal. Degenerate cells (exhibiting pyknosis or necrosis) comprised only 0.1% in control basal cells, 0.9% at day 14 of fractionation, 4.4% after the last fraction, and 0.3% back to near normal levels by 14 days later. In the 4th week of irradiation, repopulation was evident in the 52.3 Gy and 61.5 Gy dose groups. At higher doses, cell loss continued, with epidermal denudation by the end of the irradiation schedule. The extent of cell depletion and the rate of recovery of the epidermis were dose-dependent. The regenerative phase was characterized by increased cell proliferation (LI up to $20%) above that in the non-irradiated epidermis (LI $7%), from four weeks until the end of irradiation, and independent of dose. Further studies, after 2 weeks of fractionated irradiation of mouse epidermis, showed two distinctly different morphologies alternating at random over short distances [165] . In hypoplastic areas, forming $50% of the total evaluable surface, epidermal thickness was reduced and the basal nuclei were atypical. The majority of cells appeared flat and spindle shaped, while others were multinucleate or had giant nuclei. Pyknosis and karyorrhexis were observed in only a few cells. The cell density had decreased on average by 56% compared with unirradiated epidermis, and yet in other areas adjacent to the hypoplastic foci the epidermis showed significant regeneration. It was suggested that as a result of radiation injury the stem cells lose their "stemness" yet retain a capacity for some 'abortive' transit amplification divisions leading to an increase in immature keratinocytes. The importance of these abortive divisions in supporting tissue function and delaying desquamation reactions in epidermis and other epithelial sites such as oral mucosa and tongue epithelium, was emphasized by W Dörr in his treatise on "Three A's of repopulation during fractionated irradiation of squamous epithelia: Asymmetry loss, Acceleration of stem-cell divisions and Abortive divisions" [166] .
For human epidermis, the apoptotic process was investigated as direct evidence of basal cell death in punch skin biopsies obtained from a group of prostate cancer patients receiving radiotherapy [33] . After 4-5 fractions of 0.4-1.2 Gy (i.e. total dose 2-6 Gy), the apoptosis frequency in epidermis was only 30 per 50,000 cells compared to 8 per 91,000 cells in non-irradiated samples. It was concluded that the very low frequency of apoptosis suggested that this effect is not an important part of the in vivo response to these doses. This work was extended by measuring basal cell density/ mm, mitosis frequency/mm, and p21 expression/mm after the same low-dose fractions [34] . After 1 week of 1.1 Gy daily fractions, basal cell density had declined from the control value of 160/mm to 130/mm, and to 75/mm by 6.5 weeks. Mitosis frequency in the controls was 0.4/mm, so the mitotic index (MI) was 0.4/ 160 = 0.25%. After 1 week of 1.1 Gy fractions, the MI was lower at 0.1/130 = 0.08%, and by 6.5 weeks was somewhat recovered to 0.1/75 = 0.13%. The reductions in basal cell density would be due largely to continued migration to suprabasal layers and some reduced replacement, as observed in many animal systems. The very low values of MI, expected because of the short mitotic duration, cannot be attributed specifically to stem cells, progenitor cells or a combination of both without cell identification markers. The p21 index, expressed in the same way, was 15/130 = 11% at 1 week, and as high as 50/75 = 66% at 6.5 weeks. The values are indicative of widespread activation of cell cycle checkpoints, but the precise details of this are unclear in view of the various roles of p21 in cycling cells and the lack of cell type specific markers.
For human cells, in vitro assays were also used to measure radiosensitivity in cell culture. The initial survival study characterized the whole population of colony-forming primary keratinocytes from childhood foreskin, thus documenting the radiation response of a precursor population containing a majority of basal progenitor cells [167] . Whatever the mode of irradiation, which was either in vivo in intact skin sample or after one primary culture, the survival curves showed that clonogenic cells were relatively sensitive, with a Do of 0.7-0.9 Gy (dose that reduces the survival fraction to 37%). The authors pointed out that these human keratinocyte precursor cells appeared more sensitive than murine epidermal colony-forming cells in vivo (Do $ 1.3 Gy) [131] .
Obtaining further knowledge on the role of keratinocyte stem and progenitor cells required an ex vivo approach to isolate purified subpopulations, as no single marker allows discriminating in vivo on tissue sections basal keratinocytes according to their differentiation stage. The development of cell sorting using membrane markers and flow cytometry permitted the characterization of the radiation response of sorted fractionated subpopulations. This strategy has been used for human skin cells, permitting survival studies on purified fractions. Colony forming assays are particularly well adapted to human keratinocytes, as the major mode of their elimination in tissue culture after genotoxic stress is mitotic cell death, and not apoptosis, similarly to what was found in vivo in animal models. This assay is also well adapted to low-dose studies, but it differs from in vivo assays notably by the fact that colonyforming cells need to undergo more divisions to form a macroscopic colony than they would perform normally in the epidermis, similarly to a wound healing process.
Two studies confirmed that purified keratinocyte progenitors are relatively radiosensitive cells, whereas they showed that the most immature cells from the basal layer, corresponding to a stem cell state, appeared to be relatively radioresistant. First, cells isolated from epidermis and rapidly adhering to collagen type IV, with a high level of expression of b1 and a6 integrins and p63, were found more protected from apoptosis than their more differentiated progeny, via an integrin signaling pathway and in a Bcl-2 dependent manner [168] . Then another study used the phenotype ITGa6/CD71 [143] to select basal keratinocytes, based on a high capacity of adhesion to the basal lamina and slow-cycling characteristics. The population enriched for stem cells (a6 bri / CD71 dim ) was found resistant to g-irradiation (2 Gy) using a colony assay, whereas their direct progeny, the keratinocyte progenitors (a6 bri /CD71 bri ), were much more sensitive to the same dose [12] . A XTT assay, which requires only one or a limited number of cell divisions, revealed 30% mortality in progenitors at 72 h after exposure and none in the stem cells. Colony assays, which require at least six population doublings, showed that 82% of stem cells survived at 2 weeks, as compared to only 29% for the progenitors.
In the same study, a transcriptome analysis performed to compare the genomic responses to radiation (2 Gy) of the two populations revealed that one of the most striking responses of stem cells was the repression of a network of genes involved in cell death processes. Another type of mechanism was found in the same model, related to the stem cell niche, as the secretion of the FGF2 growth factor, induced specifically in stem cells by radiation, was shown to participate to the stem cell resistance [156] . Stem cell protection by its microenvironment has been poorly studied after IR, although it has been proposed that these cells benefit from a hypoxic protective niche in epidermis. Furthermore, in the holoclone model, assessment of radiosensitivity in the progeny of a single cloned stem cell also showed epidermal stem cell resistance for high radiation doses and also extended this specificity to low radiation doses, ranging from 10 to 500 mGy (MT Martin et al., unpublished data).
The relative radiosensitivity of keratinocyte progenitors found in vitro can also be compared to data obtained in skin punch biopsies taken before and during radiotherapy from prostate cancer patients undergoing radiotherapy [33, 35] . Focusing on the response of basal cells to medium and low radiation doses (1 Gy to 100 mGy fractions), the authors described a reduction in basal cell density during the protracted irradiations, likely due to continued migration to suprabasal layers and some reduction in renewal. Notably, a low-dose hypersensitivity persisted throughout the 7 weeks of RT, with a cell growth-arrest response mediated by the activation of the cell cycle checkpoint protein p21 [34] . As stem cells are largely out-numbered by keratinocyte progenitors in the basal layer, this general early cell response probably represents that of keratinocyte progenitors, but biomarker identification would be needed to confirm the affected cell types.
Thus the current knowledge on purified cell populations from the basal layer of human epidermis and on radiotherapy patient skin reactions supports the notion that cell response to radiation varies as a function of keratinocyte degree of immaturity and quiescence (Fig. 4) . The relative radioresistance of the most immature, quiescent cells can thus favour the maintenance of the stem cell pool and the rapid reconstitution of a damaged tissue [169] . However, now that a larger combination of markers of immaturity is available, a further delineation of basal keratinocytes would be necessary to investigate more precisely the question of radiosensitivity versus immaturity. The recent possibilities to characterize responses at the single cell level will almost certainly bring new knowledge and concepts, notably on the dynamics of cell states and cell lineages.
The resulting late effects of these initial responses to radiation are a major issue, which is still not fully understood. After highdoses, where toxicity and cell death take over the adaptive responses of the cells, and this even for the resistant stem cells, the major risk for the tissue is the depletion of the stem cell pool, which can impair keratinopoiesis and skin regeneration. In case stem cells have resisted cell death although the repair of damage has been incomplete, several scenarios can be postulated. Firstly, cellular specificities like epigenetic patterns of nuclear or Fig. 4 . Modeling IR responses of keratinocytes according to their differentiation status. The current knowledge on purified cell populations from the human epidermis supports the notion that radiosensitivity varies as a function of keratinocyte differentiation and proliferation status. In the present model, based on data obtained using XTT and colony survival assays (2 Gy, gamma rays, 0,2 to 0,6 Gy/min), quiescent and slow-cycling cells, including stem cells and the most earliest progenitors, are relatively radioresistant. The most sensitive cells to growth arrest and mitotic death are the cycling fraction of progenitors. The major cell death response to high-dose IR of stem cells and cycling progenitors is mitotic failure and abortive divisions. Finally, late progenitors, which progressively differentiate and exit the cell cycle, are less responsive to cell death but may respond by abnormal differentiation and migration to the upper layers of epidermis. Suprabasal quiescent and differentiated keratinocytes are not subjected to mitotic death but may participate in epidermal dysplasia, through deregulated differentiation processes.
mitochondrial DNA can perturb cell activities and result in late sequelae in epidermis. Epigenetic changes, such as methylation and acetylation, in genes involved in cell metabolism, membrane integrity and energy status, might be key events to trigger epidermis sequelae, in conjunction with signals coming from the underlying dermis, including immune regulation and inflammation. Such abnormal patterns of growth control and differentiation are clearly found in the dysplastic epidermis of radiotherapy patients at 7 weeks [34] . Similarly, irradiation of keratinocyte stem cells before skin regeneration can result in impaired differentiation of epidermis, even after doses lower than 100 mGy, and persistent nuclear DNA methylation changes could trigger this process (MT Martin unpublished data).
Genomic stability
The second scenario is where a damaged stem cell resists cell death and is maintained in the basal layer, although its DNA sequence has been modified. In that case, genomic instability might occur in this cell and in its progeny, potentially triggering the onset of carcinogenesis. Thus the question of the stem cell capacity to maintain genomic stability is a key issue [169] . This maintenance can be realized through different mechanisms, some specific to stem cells and others which are common with the differentiated cells, but operating with a higher efficiency.
The first mechanism is quiescence, which is possible because a functional hierarchy exists in epidermis. The most primitive cells, responsible for the long-term renewal of the tissue, divide at a low rate. Thus, the risk of accumulation of replication errors, as well as fixation of mutations induced by DNA damaging agents, is reduced in the stem cell population. The higher proliferation rate necessary for turnover of the epidermis is maintained by the direct progeny of the stem cells, or progenitors, which divide actively, and which are regularly eliminated by the process of terminal differentiation.
Asymmetrical cell division is another mechanism protecting stem cells from replication errors in DNA that was proposed to be specific to stem cells. This mechanism has been demonstrated in human and mouse skin, where basal epidermal cells use their polarity to divide asymmetrically [170] . J Cairns [171] proposed and then C Potten [172] elaborated that an asymmetrical chromosome segregation may also occur and result in an immortal template DNA strand remaining in the stem cell and a newly constituted strand being in the progenitor cell. To address this question, a strategy was developed to count bulge cell divisions in mouse hair follicles after labelling with BrdU. This study provided quantitative data supporting the long-standing infrequent stem cell division model, but also showed that hair follicle stem cells do not retain the older DNA strands or sort their chromosomes [173] .
To maintain their genomic stability, it was postulated that stem cells have developed appropriate mechanisms to efficiently eliminate the damaged cells. Cell death, induction of differentiation or senescence of any damaged stem cells can be a definitive solution to avoid deleterious long-term effects. Another potential mechanism, discussed below, concerns the possible plasticity of differentiated cells reverting to a stem-cell-like state. A further mechanism discussed for other tissues involves competition between undamaged and damaged stem cells for residence in the niche [174] , but this has not been reported in the case of skin.
A major mechanism of resistance to IR is activation of DNA repair. In keratinocytes selected with the ITGa6/CD71 phenotype, human keratinocyte stem cells showed more rapid repair of global DNA damage than in progenitor cells. This result was obtained using the comet assay, which under alkaline conditions measures mainly single-strand breaks. Moreover, DNA double-strand breaks, measured by the gH2AX assay, were also repaired more rapidly in keratinocyte stem cells than in progenitor cells. Taken together, these data show that the basal layer of human epidermis contains two cell populations with different DNA repair capacities, with the minor, quiescent stem cell population exhibiting a more rapid and efficient repair than the large progenitor cell population [156] .
Similarly, stem cells from the mouse follicle bulge were found capable of activated DNA repair capacity. Keratinocytes isolated on the a6 + /CD34 + phenotype (hair follicle bulge cells) were compared to cells with the a6 + /CD34 À phenotype, which represent all the other types of keratinocytes. The repair of both single and double strand DNA breaks was more rapid in the bulge cells, and the NHEJ repair pathway was found involved in this rapid repair, through DNA-PK activity [175] . Finally, activated cell signaling was another possible mechanism of stem cell resistance. Using the phenotype ITGa6/CD71, activation of the FGF2 pathway by DNA damage was investigated in stem and progenitor cells. The results revealed that the FGF2 signaling pathway was induced by DNA damage in stem cells and not in progenitor cells. To examine the role of this endogenous FGF2 in DNA repair, stem cells were exposed to FGF2 pathway inhibitors. Blocking the FGF2 receptor FGFR1 or the kinase MAPK1 resulted in inhibition of DNA single and double-strand-break repair in the keratinocyte stem cells. Moreover, supplementing the progenitor cells with exogenous FGF2 activated their DNA repair. The authors proposed that FGF2 helps to maintain genomic integrity in stem cells by activating stress-induced DNA repair [156] .
The recent data obtained on human cells and in mice highlight the importance of decrypting the DNA damage response in stem cells. If the increased repair rate observed is an intrinsic property of epidermal stem cells, the question of the repair fidelity is crucial concerning the possible late effects of radiation exposure, such as keratinocyte transformation. In vitro transformation of normal human keratinocytes is not a common process. Studies on whole populations of keratinocytes reported that exposing normal cells in tissue culture to various graded doses of irradiation failed to show any evidence of transformation [176, 177] . When cells were irradiated with 8 fractions each of 2 Gy over several months, and then selected in medium which caused cessation of growth (low EGF concentration and high calcium conditions), one clone escaped senescence but failed to form tumours in nude mice [177] .
Two studies [156, 175] point to NHEJ as a mechanism of repair for DNA damage in the stem cell population, which can be an error prone mechanism of repair. In contrast, keratinocyte progenitors exhibited a slow and incomplete repair, which appears potentially at high risk for cell transformation. In fact, a long-term study of genomic instability in cultured clones of progenitors irradiated with 2 Gy resulted in the occurrence of transformed clones with a surprising high incidence (MT Martin, unpublished data). However, in vivo, the differentiation process should limit this risk, as keratinocyte progenitors regularly migrate to the upper layers of epidermis to progressively reach terminal differentiation. An important issue will be to develop cell transformation assays on purified populations to better characterize the risk for human stem cells and for the different types of keratinocyte progenitors. New models of 3D skin cultures or human grafts in immunecompromised mice could provide relevant conditions to address this issue [69] .
Cell origin of carcinogenesis
Cell origin of human skin cancer
One of the core questions in cancer biology relates to the identity and nature of the cancer "cell of origin," the target cell in which the first oncogenic driver mutation occurs and leads to tumour initiation. Thus, despite the well-elucidated understanding of SHH signaling to BCC, the cell of origin of BCC remains controversial. Further complicating this issue are the multiple subtypes of tumours, including superficial and nodular BCC variants, which raise the possibility that different subtypes may arise from different epidermal cellular compartments [178] . Moreover, whether BCC and SCC come from the same target cell through acquisition of separate genetic events, or from completely distinct cell compartments, is still controversial issue [179] .
Several models have been proposed concerning skin cell lineages and cancer type, most of them speculating that the phenotype of epidermal carcinoma is related to the stage of differentiation of keratinocytes in which the initial oncogenic event has occurred. In one model, mutated epidermal stem cells would give rise to BCC, early progenitors would form SCC, and late progenitor cells would be the origin of papillomas, whereas stem cells of the hair follicle would give rise to trichoepithelioma [180] (Fig. 5) .
The principle of the involvement of stem cells and progenitors in human carcinogenesis is illustrated in the case of UVR-induced TP53 mutations in human interfollicular epidermis [181] . Numerous cells with TP53 mutations can be found in sun-exposed, clinically-normal human epidermis. Both scattered single cells and clonal patches of mutated cells are observed throughout exposed epidermis. The single mutated cells are predominantly suprabasal, terminally-differentiating cells. The size and distribution of TP53-mutated patches can be compared with the distribution of stem and progenitors, identified on the basis that stem cells have relatively higher b1-integrin expression and they tend not to be actively cycling. Some clones were small and restricted to the progenitor compartment, suggesting that they have arisen from a progenitor cell founder. Other clones were larger and their location was consistent with a stem-cell founder. Some of these large clones encompassed several clusters of stem cells. As the location of large patches of TP53 mutated cells is selective for stem-cell-rich regions, the authors proposed that only epidermal stem cells have the capacity to substantially propagate UVR-induced genetic alterations.
However, oncogenic events or tumour promoters might also reactivate a stem-cell programme with self-renewal ability in a target cell without stem cell characteristics. Although not demonstrated for skin, this mechanism has been proposed by some authors [182] . The initiated 'de novo stem cell' might have an increased adhesion potential, so consequently it would avoid being discarded by the normal desquamation process, notably by reexpressing high levels of adhesion molecules, such as b1 and a6-integrins, similarly to stem cells. This newly acquired self-renewal capacity could allow these cells to remain within the epidermis long enough for other oncogenic events to accumulate. 'De novo stem cells' could therefore produce a tumour tissue by establishing an altered hierarchical organization within the previously normal tissue. The authors thus proposed that all basal cells may be at the origin of cancer. On another hand, mutations may accumulate in stem cells even while the effects of the mutations are expressed in restricted progenitors. That is, mutations that accumulate in stem cells may lead to neoplastic proliferation of primitive progenitors downstream of stem cells. Concerning the differentiated keratinocytes, as none of the benign skin lesions that arose from the suprabasal layers of epidermis progressed to malignancy, the authors also stated that reactivation probably does not occur in these differentiated keratinocytes.
Markers of normal stem cells can be used to address the cell origin of tumours. Squamous carcinomas express high levels of proteins which are normally found in the basal layer of epidermis, including p63, which is required for proliferation and maintenance Fig. 5 . Modeling the cell origin of human skin cancer. Several models have been proposed concerning skin cell lineages and cancer type. Some of them speculate that the type of epidermal carcinoma is related to the stage of differentiation of keratinocytes in which the initial oncogenic event has occurred. Thus mutated epidermal stem cells would give rise to BCC, early progenitors would form SCC, and late progenitor cells would be at the origin of papillomas, whereas stem cells of the hair follicle would give rise to trichoepithelioma (reviewed in [180] ). Other models also include that oncogenic events or tumour promoters might reactivate a stem-cell programme with self-renewal ability in a target cell without these characteristics. As IR appears to essentially increase the incidence of cancer without modifying the type of skin tumours, this modeling may also apply to radiation carcinogenesis. of basal keratinocytes [183, 184] , and a6-integrin, whose expression is enriched in epidermal stem cells [141] . Prominin-1 (CD133) is stem cell marker described in several tissues. It was used to demonstrate that tumour-initiating cells are present in SCC, using in vivo xenograft assays that propagate human carcinoma. A small subset of SCC cells ($1%) expressing prominin-1 was highly enriched for cancer stem cells (1/400) compared to unsorted SCC cells (1/106 [185] . Such expression of stem-cell markers might reflect the stem cell origin of the tumour. However, it remains possible that these markers are induced by the oncogenic events that occur after the initiation of neoplastic growth. In summary, although most data point to a role of stem/ progenitor cells, it is not yet fully demonstrated which cells are at the origin of human skin cancers.
Cell origin of SCC in mice
The most common epithelial tumours of the mouse skin are papilloma and SCC. Evidence that skin tumours arise from epidermis keratinocyte precursors, either stem and/or progenitor cells, was initially provided by the two-step model of rodent skin carcinogenesis. DMBA, the initiator, was painted onto the skin, causing mutations (initiation) in cancer-initiating genes (Hras gene). However, tumours will not arise unless a proliferative stimulus is also given by TPA (promotion). The time between initiation and promotion is the critical factor in implicating the stem cell as the initiated cell. This interval can be days, or even months or years in length. Given that all epidermal keratinocytes turn over completely every 2-3 weeks in mice, except for the stem cells capable of self-renewal, it was postulated that the only way in which the initiated cells could still be present would be for initiation to have occurred in a resting stem cell population [186] . Another strong argument was that several oncogenic events are required to transform a normal cell into a squamous carcinoma cell, so only long-term residents of the epidermis, and therefore presumably stem cells, have the ability to accumulate the number of genetic hits that are necessary to result in SCC formation [181] .
Genetic engineering has been used to demonstrate that SCC can arise from the hair follicle. When oncogenic Hras was driven by a truncated keratin-5 promoter that was expressed preferentially in the hair follicle of adult mice, the mice developed papilloma and malignant carcinomas [187] . The role of the bulge in carcinogenesis was investigated, as it is the major stem cell reservoir in the mouse hair follicle. Using GFP labelling to isolate different bulge cell populations, it has been demonstrated that oncogenic Hras and Trp63 cooperate to induce premalignant properties in these keratinocytes. Moreover, it was shown that, within bulge stem cells, the induction was found only in the K15 + subpopulation, and not in the nestin + subpopulation. These data support the proposition that K15 + bulge stem cells are a tumour-initiating population in SCC [188] . Models using genetic engineering have also been developed to define the comparative roles of interfollicular epidermis and hair follicles. Using Hras oncogene driven by promoters that are selectively expressed during keratinocyte terminal differentiation, it was found that the only tumours to form in epidermis suprabasal cells were benign papillomas which tended to regress [189] . An active mutant of Kras knocked-in to its own locus was used, resulting in expression of this oncogene at a physiological level in different epithelial compartments. This expression led to papilloma formation in interfollicular epidermis. In hair follicles, expression of Kras induced papilloma formation in different cell lineages, including hair follicle bulge stem cells and their immediate progeny (hair germ and outer root sheath cells), but not in the TA matrix cells nor the hair shaft progeny cells. To initiate invasive SCC from hair follicles, combined expression of oncogenic Kras and Trp53 deletion was necessary [190] . These data show that multiple epidermal compartments of the skin are competent to initiate the early phases of squamous tumour development. Stem cell markers have been used in a number of studies to also address the origin of SCC. However, it has now been demonstrated in several models that these markers can be reactivated in tumours and they are not indicative of the initial target cell.
In summary, concerning the cellular origin of mouse SCC, transforming events in stem cells and/or progenitors of both epidermis and hair follicle are the most frequent early events that lead to SCC formation. However, incomplete results have been reported regarding the determination of which epidermal lineages give rise to these cancers. For hair follicles, specific bulge subpopulations can be direct tumour-initiating cells, although the role of other precursor populations described in HF has still to be investigated. For interfollicular epidermis, the characterization of the basal keratinocyte precursors which are initiating cells remains incomplete. The aspect in which mouse models have been most informative is the mechanisms underlying SCC development, notably on the implication of transcription or epigenetic factors. For example, using a conditional deletion of Twist1 at different stages of skin carcinogenesis, this factor, known as a driver of epithelial to mesenchymal transition, was recently shown to be required for skin tumour initiation and progression of mouse SCC in a gene-dosage-dependent manner [191] . Epigenetic mechanisms largely participate in carcinogenesis, at the DNA [192] or RNA level [193] . The question of a stem cell origin of SCC after exposure to IR has not been fully investigated.
Cell origin of BCC in mice
Mice normally do not develop BCC, thus genetic engineering was necessary to obtain cutaneous BCC in mice and assess the origin of these tumours. As 85% of human BCC are caused by mutations in genes of the SHH pathway, vectors targeting this pathway at different levels were used in mice. In models of sporadic tumours, the numerous studies performed provided confusing and sometimes contradictory results [179, 194, 195] . Using mice conditionally expressing constitutively active Smoothened (Smo) mutant, Shh signaling was activated in different cellular compartments of the skin. Activation in hair follicle bulge stem cells and their TA progeny did not induce cancer formation, demonstrating that BCC does not originate from bulge stem cells in this model. Using clonal analysis, it was shown that BCC arises from long-term resident progenitor cells of the interfollicular epidermis and the upper infundibulum [196] . Another study showed that induction of a major mediator of Shh signaling, Gli2 activator, selectively in stem cells of resting hair follicles in mice, induced nodular BCC development from a small subset of cells in the bulge and hair germ compartments. In contrast, induction in epidermis led to the formation of superficial BCC. Thus the cell of origin and tissue context (quiescent versus growing hair follicles) can determine the phenotype of Shh-driven skin tumours, with oncogenic signaling required for development of superficial BCC-like tumours from interfollicular epidermis and nodular BCClike tumours from hair follicle stem cells [197] . Recently, Peterson et al. demonstrated that, by using several inducible Cre drivers to delete Ptch1 in different cell compartments in mouse skin, basal stem cells within the epidermis do not efficiently form BCC-like tumours, but that they can arise from the touch dome epithelia, which is an upper mechanosensory organ, involved in the activation of Shh signaling during homeostasis [199] . In hair follicles, multiple stem cell populations formed BCC in response to Ptch1 deletion [198] .
From these different studies, it can be concluded that the stem/ progenitor cells appear to be the major targets of BCC carcinogenesis in mice, and that targeting the Shh pathway at different levels, from the membrane receptor to the nuclear Gli transcription factor, results in an oncogenic response but in different stem cell compartments and with substantial variations in location on the mouse body. These contradictory results may be due to different experimental strategies, including mouse strain genetic backgrounds, different genetic events used to activate Shh, different tissue-specific promoters to drive oncogene expression, and locations of tumours, or more generally to the artificial development of BCC in mice.
To characterize radiation-induced tumours, Ptch1 heterozygous knockout mice have provided important tools for the study of IRinduced tumourigenesis. In one model, basaloid hyperproliferative areas were found to originate from the hair follicle and interfollicular epidermis, but the origin of the infiltrative BCClike tumours that could later develop from the preneoplastic lesions was not defined [199] . Later, using the same Ptch1 +/À mouse model, this group showed that IR induced two subtypes of BCC. An early onset of BCC occurred in a hair cycle-dependent manner, producing tumours with fast growth and SMA expression. They proposed that these tumours originated from hair follicle outer root sheet progenitors. Later, conventional BCC appeared, with slow growth, no SMA expression, which might arise in majority from interfollicular epidermis stem cells, with a possible contribution of hair follicle bulge [200] . Using a different mouse model targeting Ptch1, another group confirmed two subtypes of tumours but found that X-ray-induced BCC were found exclusively to arise from the population of cells that express keratin 15, and notably from the bulge stem cells [201] . In epidermis, BCC development would require additional loss of p53 and enhanced Smo expression, which is consistent with the reported little or no expression of Shh pathway in the normal mouse adult epidermis.
Summary and conclusions
Improvement has been made in characterizing the target cells of adverse reactions of skin to radiation. Data obtained from human cells studies and radiotherapy patients similarly converge to a model where the slow-cycling stem cell, well protected in the niche, develops specific protections to the genotoxic stress, including specific cell signaling, DNA repair capacities and repressed cell death pathways. On the contrary, their direct progeny, the numerous, cycling progenitors of the basal layer, exhibits higher sensitivity to IR, with lower DNA repair capacity and stress signaling. The major mode of basal cell response to high IR doses appears to be mitotic abnormalities and not apoptosis, yet allowing some divisions of progenitor cells and abortive divisions of stem cells which contribute further suprabasal cells to the prominent latency of epidermal reactions. Also of interest is the demonstration that radiation doses below 100 mGy can affect epidermis homeostasis and renewal. However, the role of specific sorted populations of progenitors, from early to late differentiation stages, still has to be better elucidated. The new approach at a single cell level developed by cellular biologists, in cooperation with bioinformaticians, will undoubtedly bring new concepts both on basal cell hierarchy, stem cell state and cell responses to stress. Recent data, notably after a low or chronic stress, point to metabolic activities localized at cell membranes and in mitochondria, cell energy status, cell-cell interactions and relations to the niche components as other important targets of IR. The role of keratinocyte stem cells in late effects of radiation in normal tissues is probably central, as other basal cells than stem cells are regularly dispensed from the epidermis via the normal desquamation process. Epidermal dysplasia is a frequent signature of exposure, but the mechanisms leading to either hypo-or hyperplasia are not yet fully characterized.
The role of stem cells in radiation carcinogenesis is also still poorly defined. One clear result is that most human epithelial skin tumours arise from keratinocyte precursors in the basal layer of the epidermis, whereas differentiated keratinocytes give rise to benign lesions such as papillomas. Multiple data argue that epidermal stem cells can be at the origin of BCC. The model proposed by Sell [180] , in which the type of carcinoma depends on the level of differentiation of the initially-modified cells, is a relevant working model for skin radio-carcinogenesis. However, some types of progenitor cells, still to be defined, probably also participate in carcinogenesis, through reprogramming processes.
Trying to answer some of the remaining questions will require fundamental stem cell studies to better characterize the different types of keratinocytes within the basal layer of human epidermis and the other epithelial skin structures. Relevant 3D models, either in vitro or after grafting in immune-compromised mice, are necessary for improving radiobiological knowledge, including those for skin cancer. Concerning the target genes, although PTCH1 and TP53 appear key players in human skin radio-carcinogenesis, further characterizing the target genes and associated mutations in skin stem and progenitor cells will benefit from the from nextgeneration sequencing and the recent techniques permitting genome editing on targeted genes using CRISPR/Cas9 technology. Another stimulating question is whether non-mutational processes, which contribute to human health risk including cancer, may vary according to cell differentiation. Thus characterizing nonmutational processes, collectively known as epigenetic effects, including DNA methylation, chromatin modification and modulation of non-coding RNA expression, is another avenue of research concerning stem cell functions, adverse skin reactions and cancer development.
